RE: multi baggers and covid stocks6 May 2020 15:05
trottersindtrade, I agree this stock has matured and has become much less high risk.
- Cash in the bank, no risk of placings
- Warrants gone
- only 68M shares in issue
- Has a product right now with many world-wide approvals
- Secured forward orders with UK government, with an option to supply more (looks like that will happen now target is 200K per week)
- Rumours of WHO order and I'm sure we'll bag the French order for 700K tests per week
- We have already ramped up production to 8M tests and has plans to further increase
- Innovation with the dPCR test due to be released removing the need for reagents and reducing test time
- We've appointed a consultant to help source manufacturing materials / chemicals
- There's a worldwide distribution network in place
Meanwhile many of the other shares are having placings and don't even have approved product to sell.
Our CEO has delivered well so far for share holders, I can only see a good future especially when dPCR comes in to play and the orders pile in due to the shortage if reagents.